Results: Anti-platelet Activity of Brilliant Blue FCF
8:29
Conclusion
Transcript
The overall goal of this procedure is to describe a straightforward method for the isolation of washed platelets from human blood followed by agonist-induced platelet aggregation measurements by turbidimetry. This method can help answer key questi
Sign in or start your free trial to access this content
We describe a straightforward method for the isolation of washed platelets from human blood followed by agonist-induced platelet aggregation measurements by turbidimetry. As an example we apply this method for studying the aggregation response of human platelets to collagen after a pre-incubation with the Pannexin1 channel inhibitor Brilliant Blue FCF.